Discover & Learn

IBA today launches Cyclone^® iKure, a dedicated cyclotron for routine Astatine-211 (²¹¹At) production. Designed for alpha-beam irradiation, this new cyclotron enables radiopharmaceutical manufacturers, research institutions and healthcare providers to accelerate access to targeted alpha therapies with the reliability and quality required for clinical-scale programs.

The Future of Astatine is here

At SNMMI 2026, discover the latest IBA Astatine-211 dedicated technologies —where precision, reliability, and performance come together for alpha-based targeted cancer therapies.

Be there to celebrate together the Future of Targeted Alpha Therapy, a special moment to connect and celebrate around light refreshments.

Seats are limited → book your seat now
 

• Sunday, May 31 – 3.30 PM
• IBA booth #2023

As we wrap up the year 2025, we want to thank our incredible IBA community, from users, partners, colleagues and followers for making this year so incredible.

Cutting-edge science meets innovation! We are very delighted to launch CASSY®, our new radiochemistry module designed for unmatched efficiency and versatility!

“We have a contract with IBA for 2 preventive maintenances per year for 3 sites. We have hotline support by e-mail and remote support for software problems. I think they are very important because without technical support, we couldn't solve some hard problems.”
 

Milos Orlik, Cyclotron Operator
ÚJV Řež, a. s.

"Every time I need to speak with someone, I can reach them very easily. The service agreement helps me avoid having downtime on the machines."
 

Simone Rossi, Technician
San Rafaele Hospital, Milan